drugset
drugset / Trial / NCT02473198

Femoral Nerve Block Compared to Exparel in Total Knee Replacement

NCT02473198 ↗

Phase 3 Unknown 312 enrolled The New England Baptist Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The main objective of the study is to determine if intrarticular injection with liposomal bupivicaine (Exparel) provides better postoperative pain relief and functional outcome following total knee replacement (TKR) than the current standard New England Baptist Hospital regimen of femoral nerve block combined with intraarticular injection of a standard bupivicaine solution.

Timeline

Start
2014-01
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml Other
Background Ketorolac Tromethamine Small molecule 30 mg Other
Background Morphine Other / unclassified 10 mg Other

Indications

osteoarthritis